Patents by Inventor Michael Traeubel

Michael Traeubel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7914816
    Abstract: The present invention relates to pharmaceutical presentations for animals which are administered orally and which are accepted readily by the animals (for example dogs, cats and horses), to processes for their preparation and to their use, in particular as endoparasiticides.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: March 29, 2011
    Assignee: Bayer Animal Health GmbH
    Inventors: Jochen Kalbe, Kornelia Geiβler, Michael Träubel, Achim Harder, Georg von Samson-Himmelstjerna
  • Publication number: 20110046072
    Abstract: The invention relates to a solid pharmaceutical preparation with delayed release of the active ingredients which is suitable in particular for use in animals.
    Type: Application
    Filed: April 23, 2009
    Publication date: February 24, 2011
    Applicant: BAYER ANIMAL HEALTH GMBH
    Inventors: Venkata-Rangarao Kanikanti, Thomas Bach, Michael Traeubel, Gertraut Altreuther, Martina Rehagen, Axel Schmidt
  • Patent number: 7763583
    Abstract: The present invention relates to transdermally applicable compositions comprising cyclic depsipeptides and/or praziquantel, and to their preparation and their use for controlling endoparasites.
    Type: Grant
    Filed: June 13, 2006
    Date of Patent: July 27, 2010
    Assignee: Bayer Animal Health GmbH
    Inventors: Venkata-Rangarao Kanikanti, Thomas Bach, Gertraut Altreuther, Michael Traeubel, Hans-Juergen Hamann
  • Publication number: 20040077291
    Abstract: Disclosed herein is a beehive entrance dimensioned or equipped with an entrance gate device comprising an anti-parasitic agent having a means for restricting bees from flying into the hive, and compelling the bees to effectively contact the anti-parasitic agent
    Type: Application
    Filed: October 10, 2003
    Publication date: April 22, 2004
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Robert G. Arthur, Michael Grosse-Bley, Hans-Dieter Hamel, Josef Heine, Ulrich Heukamp, Michael Traeubel, Otto Wilinski, Nikolaus Koeniger, Stefan Fuchs